General Information of the Compound
Compound ID
CP0962699
Compound Name
4-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)isoquinoline
    Show/Hide
Structure
Formula
C21H22N6
Molecular Weight
358.449
Canonical SMILES
c1ccc2c(-c3ncnc4c3cnn4CCN3CCCCC3)cncc2c1
    Show/Hide
InChI
InChI=1S/C21H22N6/c1-4-8-26(9-5-1)10-11-27-21-19(14-25-27)20(23-15-24-21)18-13-22-12-16-6-2-3-7-17(16)18/h2-3,6-7,12-15H,1,4-5,8-11H2
    Show/Hide
InChIKey
WGJJNLXFZBPSLW-UHFFFAOYSA-N
Physicochemical Property
logP
3.5274
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
59.73
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 74767050
ChEMBL ID
CHEMBL4281627
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 666 nM
   TI
   LI
   LO
   TS